EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of active systemic lupus erythematosus with the prolactin lowering drug, bromocriptine Comparison with hydroxychloroquine in a randomized, blinded one-year study



Treatment of active systemic lupus erythematosus with the prolactin lowering drug, bromocriptine Comparison with hydroxychloroquine in a randomized, blinded one-year study



Arthritis & Rheumatism 42(9 SUPPL ): S282, Sept




(PDF 0-2 workdays service: $29.90)

Accession: 035980733

Download citation: RISBibTeXText



Related references

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. New England Journal of Medicine 324(3): 150-154, 1991

Treatment of active systemic lupus erythematosus with bromocriptine. Clinical Research 42(3): 412A, 1994

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. New England Journal of Medicine 324(3): 150-154, 1991

Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. Journal of Rheumatology 21(8): 1457-1462, 1994

Bromocriptine in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled study. Lupus 7(6): 414-419, 1998

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 7(2): 80-85, 1998

Effects of prolactin and therapy with bromocriptine on systemic lupus erythematosus. Journal of Autoimmunity (SUPPL ): 10, 1999

Hydroxychloroquine Effects on Lipoprotein Profiles (the HELP trial): A Double-Blind, Randomized, Placebo-Controlled, Pilot Study In Patients With Systemic Lupus Erythematosus. Journal of Clinical Rheumatology 3(1): 3-8, 1997

Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. Lupus 21(11): 1178-1182, 2013

Treatment of systemic lupus erythematosus with dehydroepiandrosterone Follow-up data from a double-blinded, randomized, placebo controlled, clinical trial. Arthritis & Rheumatism 37(9 SUPPL ): S369, 1994

Treatment of systemic lupus erythematosus with dehydroepiandrosterone, interim analysis of a double-blinded, randomized, placebo controlled, clinical trial. Arthritis & Rheumatism 36(9 SUPPL ): S92, 1993

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis and Rheumatism 62(1): 222-233, 2010

Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction. Journal of the American Society of Echocardiography 18(9): 981-981, 2005

Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?. Joint, Bone, Spine 77(1): 4-5, 2010